Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands

Blood Cancer J. 2021 May 11;11(5):87. doi: 10.1038/s41408-021-00482-8.

Hidde L A Posthuma^{1

2}, Josée M Zijlstra³, Otto Visser⁴, Marie José Kersten⁵, Pieternella J Lugtenburg⁶, Avinash G Dinmohamed^{3

5

7

8}

¹ Department of Internal Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands. [email protected].
² Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. [email protected].
³ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
⁴ Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁵ Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
⁶ Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands.
⁷ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁸ Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands.

No abstract available

Publication types